# EDGAR Filing Document

**Accession Number:** 0001834489
**File Stem:** 0000000000-23-000045
**Filing Date:** 2023-1
**Character Count:** 7205
**Document Hash:** 8db4364832ab652106a6f92d455ff7e2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000045.hdr.sgml**: 20230406

**ACCESSION NUMBER**: 0000000000-23-000045

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230103

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genius Sports Ltd
- **CENTRAL INDEX KEY:** 0001834489
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** Y7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 10 BLOOMSBURY WAY, 9TH FLOOR
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** WC1A 2SL
- **BUSINESS PHONE:** 44 (0) 20 7851 4060

**MAIL ADDRESS:**
- **STREET 1:** 10 BLOOMSBURY WAY, 9TH FLOOR
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** WC1A 2SL

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Galileo Newco Ltd
- **DATE OF NAME CHANGE:** 20201202
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-22-288537

## Text-Extract

```

United States securities and exchange commission logo

                             January 3, 2023

       Ross M. Leff
       Partner
       Kirkland & Ellis LLP
       601 Lexington Avenue
       New York, New York 10022

                                                        Re: Genius Sports Ltd
                                                            Schedule TO-I/A
filed December 20, 2022
                                                            SEC File No.
5-93523
                                                            Form F-4/A filed
December 20, 2022
                                                            SEC File No.
333-268457

       Dear Ross M. Leff:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

               Please respond to these comments by providing the requested
information or advise us as
       soon as possible when you will respond. If you do not believe our
comments apply to your facts
       and circumstances, please tell us why in your response.

               After reviewing your response to these comments, we may have
additional comments.
       All defined terms have the same meaning as in your prospectus.

       Schedule TO-I/A filed December 20, 2022

       General

   1.                                                   We note the revised
disclosure that if the Warrant Amendment is approved, any warrant
                                                        that is not exercised
by the Expiration Date will be exercised automatically on a cashless
                                                        basis at an exercise
price that is 76.6% of the volume-weighted average price of the
                                                        ordinary shares for the
one-Trading Day period on the NYSE on the second Trading Day
                                                        prior to the Expiration
Date. However, your revised disclosure provides that this will
                                                        happen only if such
Exercise Price would be less than $11.50 per share. Revise to explain
                                                        what will happen to
warrants that are not tendered if the Exercise Price would be greater
                                                        than $11.50 per shares.
 Ross M. Leff
Kirkland & Ellis LLP
January 3, 2023
Page 2

2.       We note your revised disclosure that the company will issue a press
release announcing
         the Reduced Exercise Price prior to the opening of trading on the
Trading Day prior to the
         Expiration Date. So that warrant holders know where they can access
such press release,
         please confirm that it will be filed on EDGAR as an amendment to the
tender offer
         materials, and revise the disclosure in your offer to purchase
accordingly.
        We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

         Please direct any questions to Christina Chalk at (202) 551-3263.

FirstName LastNameRoss M. Leff                                Sincerely,
Comapany NameKirkland & Ellis LLP
                                                              Division of
Corporation Finance
January 3, 2023 Page 2                                        Office of Mergers
& Acquisitions
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

January 3, 2023

Ross M. Leff  
Partner  
Kirkland & Ellis LLP  
601 Lexington Avenue  
New York, New York 10022

**Re: Genius Sports Ltd**  
**Schedule TO-I/A filed December 20, 2022**  
**SEC File No. 5-93523**  
**Form F-4/A filed December 20, 2022**  
**SEC File No. 333-268457**

Dear Ross M. Leff:

We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to these comments by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response to these comments, we may have additional comments. All defined terms have the same meaning as in your prospectus.

Schedule TO-I/A filed December 20, 2022

# General

1. We note the revised disclosure that if the Warrant Amendment is approved, any warrant that is not exercised by the Expiration Date will be exercised automatically on a cashless basis at an exercise price that is 76.6% of the volume-weighted average price of the ordinary shares for the one-Trading Day period on the NYSE on the second Trading Day prior to the Expiration Date. However, your revised disclosure provides that this will happen only if such Exercise Price would be less than $11.50 per share. Revise to explain what will happen to warrants that are not tendered if the Exercise Price would be greater than $11.50 per shares.

Ross M. Leff
Kirkland & Ellis LLP
January 3, 2023
Page 2

2. We note your revised disclosure that the company will issue a press release announcing the Reduced Exercise Price prior to the opening of trading on the Trading Day prior to the Expiration Date. So that warrant holders know where they can access such press release, please confirm that it will be filed on EDGAR as an amendment to the tender offer materials, and revise the disclosure in your offer to purchase accordingly.

We remind you that the filing persons are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please direct any questions to Christina Chalk at (202) 551-3263.

Sincerely,

Division of Corporation Finance
Office of Mergers & Acquisitions